Rothfuss Cristin 4
4 · Sarepta Therapeutics, Inc. · Filed Mar 10, 2025
Insider Transaction Report
Form 4
Rothfuss Cristin
EVP, General Counsel
Transactions
- Tax Payment
Common Stock
2025-03-07$103.70/sh−347$35,984→ 11,847 total - Tax Payment
Common Stock
2025-03-07$103.70/sh−1,131$117,285→ 12,194 total
Footnotes (2)
- [F1]Shares were sold by the Company to satisfy tax withholding obligations related to vesting of PSUs granted on March 6, 2023.
- [F2]Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 6, 2023.